EU Agency Probes Safety Of Pfizer's Champix
The European Union's medicine watchdog has opened an investigation into the safety of Pfizer Inc.'s Champix after alarming reports suggested risks of depression and suicide in patients using the anti-smoking treatment....To view the full article, register now.
Already a subscriber? Click here to view full article